Strand Therapeutics
Developer of a medicine infrastructure platform intended to create medicines that respond to disease signals in real-time. The company's platform helps create programmable messenger ribonucleic acid t...
Valuation
$571M
Latest known
Share Price
N/A
Total Raised
$255.6M
Last Round
N/A